CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Grant or award CFO and Treasurer acquired 72,400 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,085 shares (to pay taxes)
- 4 Shares withheld for taxes President,CEO, and Interim CFO gave up 21,752 shares (to pay taxes)
- 8-K Event Bylaws or fiscal year change
- 4 Open-market sale President,CEO, and Interim CFO sold 100,000 shares at $10.72 ($1,071,980)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,085 shares (to pay taxes)
- 4 Shares withheld for taxes President,CEO, and Interim CFO gave up 21,752 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 461,716 shares at an average $6.07 ($2,803,741)
Page 9 of 50 · 1,000 filings